Translational Development Acquisition (TDACW) Free Cash Flow (2024 - 2026)
Translational Development Acquisition's (TDACW) quarterly Free Cash Flow came in at -$338753.0 in Q2 2026, down 97.7% on a YoY basis from -$14.7 million in Q2 2025, and down 11.01% quarter-over-quarter from -$305157.0 in Q1 2026.
Powered by 
Analysis
Translational Development Acquisition (TDACW) Free Cash Flow (2024 - 2026) Analysis & Trends
Translational Development Acquisition (TDACW) has reported Free Cash Flow for 3 consecutive years, with -$338753.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Free Cash Flow fell 97.7% year-over-year to -$338753.0; the trailing twelve-month figure through Jun 2026 stood at -$849378.0 (changed N/A YoY), and the FY2025 full-year result was -$608387.0, up 28.55% from the prior year.
- Free Cash Flow eased to -$338753.0 in Q2 2026 per TDACW's latest filing, from -$305157.0 in the prior quarter.
- Across five years, Free Cash Flow topped out at -$88105.0 in Q3 2025 and bottomed at -$810963.0 in Q4 2024.
- Historically, Free Cash Flow has averaged -$294751.4 across 3 years, with a median of -$231574.0 in 2025.
- The sharpest annual moves came in 2025 and 2026: Free Cash Flow surged 85.53% in 2025, then slumped 97.7% in 2026.
- Over 3 years, Free Cash Flow stood at -$810963.0 in 2024, then soared by 85.53% to -$117363.0 in 2025, then tumbled by 188.64% to -$338753.0 in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$338753.0, -$305157.0, and -$117363.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Jefferies Financial | 11.47 Bn | -3.98 Bn | 3.09 Bn | 1.55 Bn |
| 2 | Evercore | 11.13 Bn | 8.72 Bn | 975.67 Mn | 514.79 Mn |
| 3 | Houlihan Lokey | 9.10 Bn | 7.91 Bn | - | - |
| 4 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - | - |
| 5 | Piper Sandler Companies | 5.18 Bn | 4.88 Bn | - | 28.46 Mn |
| 6 | Moelis | 4.95 Bn | 4.74 Bn | - | 215.86 Mn |
| 7 | PJT Partners | 4.74 Bn | 4.13 Bn | 481.98 Mn | 226.38 Mn |
| 8 | Lazard | 4.36 Bn | 3.26 Bn | - | 199.48 Mn |
| 9 | BRBI BR Partners | 3.44 Bn | 3.32 Bn | 16.77 Mn | 22.00 Mn |
| 10 | Translational Development Acquisition | 52.67 Mn | 52.58 Mn | - | -338,753.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -338,753.00 |
| Mar 31, 2026 | -305,157.00 |
| Dec 31, 2025 | -117,363.00 |
| Sep 30, 2025 | -88,105.00 |
| Jun 30, 2025 | -171,345.00 |
| Mar 31, 2025 | -231,574.00 |
| Dec 31, 2024 | -810,963.00 |